Upon targeting TYMP with a reported optimal effective dose of TPI (150 mg/kg/day), in addition to suppression of TYMP expression in tumor tissue, ICD could be induced in vivo but simultaneously caused damage to the host immune system (Figures 4J, K) and was unable to generate a better prognosis; withdrawal of therapy regained tumor growth momentum. The gene discussed is TYMP; the disease is neoplasm.